Translate this page into:
Primary cutaneous botryomycosis
Corresponding author: Dr. Shih-Tsung Cheng, Department of Dermatology, College of Medicine, Kaohsiung Medical University, Kaohsiung City, Taiwan. tennsichong@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Wang WY, Cheng ST. Primary cutaneous botryomycosis. Indian J Dermatol Venereol Leprol. 2024;90:831-2. doi: 10.25259/IJDVL_1036_2023
A 75-year-old woman presented with a 2-year history of progressive swelling of her right fifth toe. Physical examination showed multiple tender, smooth, round-to-oval, erythematous nodules embedded in the swollen toe without discharge [Figure 1]. Non-polarised dermoscopic examination at 10× magnification revealed scattered yellowish granules of variable size [Figure 2]. Skin biopsy taken from the nodules showed dermal deposition of granules of basophilic bacterial aggregates rimmed by an eosinophilic matrix. Gram staining revealed clustered non-filamentous Gram-positive cocci, subsequently identified as oxacillin-resistant Staphylococcus haemolyticus through bacterial culture. There was no evidence of any systemic involvement. A diagnosis of primary cutaneous botryomycosis was made. The mainstay of treatment for botryomycosis consists of extended antibiotic therapy guided by sensitivity tests, frequently complemented by surgical debridement for refractory or deeply infiltrating lesions, typically resulting in favourable outcomes.1,2 The patient received combination therapy involving a 3-week course of intravenous vancomycin and surgical debridement for refractory lesions, leading to the complete resolution of the lesions.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
References
- Cutaneous botryomycosis treated successfully with injectable ceftriaxone sodium in an immunocompetent child. Indian J Dermatol Venereol Leprol. 2018;84:485-7.
- [CrossRef] [PubMed] [Google Scholar]
- Cutaneous botryomycosis in immunocompetent patients: A case series. Indian Dermatol Online J. 2019;10:311-5.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]